Sees FY24 revenue $2.47B-$2.49B, consensus $2.47B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- GMED Upcoming Earnings Report: What to Expect?
- Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
- Globus Medical receives FDA 510k clearance for ExcelsiusFlex, ACTIFY
- Globus Medical price target raised to $78 from $63 at Truist
- Globus Medical price target raised to $71 from $67 at Morgan Stanley